| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8727713 | Gastrointestinal Endoscopy | 2018 | 10 Pages |
Abstract
Diagnostic ER for cM3-SM2 esophageal cancer with or without subsequent esophagectomy was feasible and safe, not only from a surgical perspective but also an oncologic perspective. Approximately 20% of cM3-SM2N0M0 patients can potentially avoid undergoing additional treatment including esophagectomy using diagnostic ER.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Masashi MD, Koichi MD, PhD, Yasuo MD, PhD, Motohiko MD, PhD, Shuhei MD, PhD, Kayo MD, Kazumasa PhD, Rieko MD, PhD, Norihito MD, PhD, Hirofumi MD, PhD, Hiroya MD, PhD, Naohisa MD, PhD, Yuko MD, PhD,